Evrofarma SA (ATH:EVROF)

Evrofarma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.47	0.66	1.44	0.25	3.11	0.11
Cash & Short-Term Investments	0.47	0.66	1.44	0.25	3.11	0.11
Cash Growth	-76.78%	-54.28%	477.11%	-91.99%	2832.07%	-80.87%
Receivables	9.66	9.17	11.72	13.69	12.15	10
Inventory	8.89	6.52	5.56	3.07	3.57	3.08
Other Current Assets	-	-0	-	-	-	-
Total Current Assets	19.02	16.34	18.71	17.01	18.83	13.19
Property, Plant & Equipment	25.27	25.57	24.95	24.41	22.46	22.99
Long-Term Investments	0.01	0.01	0.06	0.04	0.04	0.07
Other Intangible Assets	0.03	0.05	0.06	0.1	0.13	0.17
Long-Term Accounts Receivable	0.03	0.33	0.03	0.03	0.02	0.03
Other Long-Term Assets	5.2	5.06	5.01	4.94	4.9	4.76
Total Assets	49.56	47.36	48.81	46.52	46.38	41.2
Accounts Payable	4.69	2.39	4.45	3.44	2.94	2.08
Accrued Expenses	0.35	0.5	0.45	0.87	0.32	0.26
Short-Term Debt	3.25	3.9	2.44	0.72	1.92	8.67
Current Portion of Long-Term Debt	2.84	3.08	2.71	2.5	2.63	9.19
Current Portion of Leases	0.06	0.04	0.04	0.03	0.02	0.05
Current Income Taxes Payable	0.84	0.4	0.11	-	0.02	0.01
Other Current Liabilities	1.77	2.73	2.48	2.64	2.85	2
Total Current Liabilities	13.82	13.04	12.67	10.2	10.71	22.25
Long-Term Debt	10.85	12.45	16.13	18.05	16.63	0.66
Long-Term Leases	0.14	0.07	0.06	0.01	0.01	0.02
Long-Term Unearned Revenue	5.97	4.43	4.69	4.42	4.82	5.23
Long-Term Deferred Tax Liabilities	1.08	1.08	1.18	1.18	1.19	1.1
Other Long-Term Liabilities	-	-	-0	-	-	-
Total Liabilities	31.93	31.13	34.79	33.92	33.42	29.33
Common Stock	5.74	5.74	12.03	12.03	12.03	12.03
Additional Paid-In Capital	-	-	0.94	0.94	0.94	0.94
Retained Earnings	11.89	7.42	-1.49	-0.38	-0.01	-1.1
Comprehensive Income & Other	-	3.06	2.55	0.02	-	-
Shareholders' Equity	17.63	16.23	14.03	12.61	12.96	11.87
Total Liabilities & Equity	49.56	47.36	48.81	46.52	46.38	41.2
Total Debt	17.14	19.53	21.38	21.31	21.22	18.59
Net Cash (Debt)	-16.67	-18.87	-19.94	-21.06	-18.11	-18.48
Net Cash Per Share	-1.22	-1.38	-1.46	-1.54	-1.32	-1.35
Filing Date Shares Outstanding	13.67	13.67	13.67	13.67	13.67	13.67
Total Common Shares Outstanding	13.67	13.67	13.67	13.67	13.67	13.67
Working Capital	5.2	3.3	6.04	6.81	8.12	-9.06
Book Value Per Share	1.29	1.19	1.03	0.92	0.95	0.87
Tangible Book Value	17.6	16.18	13.97	12.51	12.83	11.7
Tangible Book Value Per Share	1.29	1.18	1.02	0.91	0.94	0.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.